Blue Dot News

One story a day from the frontier of human knowledge.

Medicine ·

Medicine

New Study Reveals How Chemokines Bind to Receptors

Researchers at science advances have created detailed structures of chemokine-receptor interactions that shed light on how specific ligands bind and activate the receptor.

Illustration: Blue Dot News

1 min read

In the intricate dance of immune cells, a subtle balance is maintained by the specific interactions between chemokine receptors and their corresponding ligands. For years, scientists have been fascinated by the CXC chemokine receptor 3 (CXCR3) and its unique ability to bind multiple ligands with varying degrees of efficacy. Like skilled musicians tuning their instruments, researchers Bouyssou A et al. have carefully crafted a detailed understanding of how CXCR3 interacts with its three primary ligands: CXCL9, CXCL10, and CXCL11.

Through a combination of cutting-edge techniques such as cryo-electron microscopy and molecular dynamics, the team has been able to visualize and analyze the precise mechanisms by which these ligands bind to CXCR3. Their findings reveal that the membrane-distal N terminus of CXCR3 plays a critical role in determining the specificity and potency of these interactions. This discovery offers new insights into the complex signaling pathways activated by CXCR3, shedding light on its versatility as a receptor.

So why does this matter? The intricate balance maintained by CXCR3 and its ligands is essential for our immune system's ability to respond effectively to infection and inflammation. Dysregulation of these interactions has been implicated in various diseases, including autoimmune disorders and cancers. By gaining a deeper understanding of the molecular mechanisms underlying CXCR3 biology, researchers can develop new therapeutic strategies to target these complex processes and improve human health.

The people behind the work

  • Bouyssou A et al.

    Author

    Published in Science advances

Source: Science advances

Sources & Verification

Every statement in this story is drawn from the facts below. Each is linked to a primary or reputable source — follow any citation to check it for yourself.

  1. Here, we present cryo-electron microscopy structures of all three chemokine-CXCR3-G i complexes, complemented by cell binding studies and functional mutagenesis data. Science advances
  2. We systematically compare the pharmacological and interaction profiles of CXCL9, CXCL10, and CXCL11 to rationalize their varying efficacies and potencies and to reveal the critical role of the membrane-distal CXCR3 N terminus in ligand binding and signaling. Science advances
  3. Using chimeric chemokines and molecular dynamics, we reveal the signaling plasticity of chemokine ligands and signaling determinants. Science advances
  4. Together, these insights enable us to propose a multimodal binding and activation framework that explains CXCR3 chemokine ligand multispecificity and signaling versatility and offer tools to interrogate and modulate CXCR3 biology. Science advances

Part of the Blue Dot News 2026 retrospective — an archive reconstructed automatically from the published scientific record. The science is real and cited above; this is not original daily reporting, and it is deliberately kept out of the live news feed.

← All stories